Inovio Pharmaceuticals Stock Market Value
| INO Stock | USD 4.07 0.01 0.25% |
| Symbol | Inovio |
Inovio Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.55) | Return On Assets (0.40) | Return On Equity (0.91) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Inovio Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inovio Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inovio Pharmaceuticals.
| 12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in Inovio Pharmaceuticals on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Inovio Pharmaceuticals or generate 0.0% return on investment in Inovio Pharmaceuticals over 720 days. Inovio Pharmaceuticals is related to or competes with Novavax, Vaxart, Enveric Biosciences, Ocean Biomedical, Hepion Pharmaceuticals, and Elevation Oncology. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of D... More
Inovio Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inovio Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inovio Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 17.45 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 3.22 |
Inovio Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inovio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inovio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Inovio Pharmaceuticals historical prices to predict the future Inovio Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.42) |
Inovio Pharmaceuticals Backtested Returns
Inovio Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.26, which attests that the entity had a -0.26% return per unit of risk over the last 3 months. Inovio Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inovio Pharmaceuticals' Standard Deviation of 3.34, market risk adjusted performance of (0.41), and Risk Adjusted Performance of (0.19) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.02, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inovio Pharmaceuticals will likely underperform. At this point, Inovio Pharmaceuticals has a negative expected return of -0.88%. Please make sure to check out Inovio Pharmaceuticals' skewness, as well as the relationship between the day median price and relative strength index , to decide if Inovio Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Inovio Pharmaceuticals has insignificant reverse predictability. Overlapping area represents the amount of predictability between Inovio Pharmaceuticals time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inovio Pharmaceuticals price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Inovio Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 6.19 |
Inovio Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Inovio Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Inovio Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Inovio Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Inovio Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Inovio Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Inovio Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Inovio Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Inovio Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Inovio Pharmaceuticals Lagged Returns
When evaluating Inovio Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Inovio Pharmaceuticals stock have on its future price. Inovio Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Inovio Pharmaceuticals autocorrelation shows the relationship between Inovio Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Inovio Pharmaceuticals.
Regressed Prices |
| Timeline |
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Inovio Pharmaceuticals Correlation, Inovio Pharmaceuticals Volatility and Inovio Pharmaceuticals Alpha and Beta module to complement your research on Inovio Pharmaceuticals. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Inovio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.